Department of Anesthesiology and Critical Care, Imam Khomeini Medical Complex, Tehran University of Medical Sciences, Tehran, Iran.
Al-furat Al-awsat Hospital, Al-furat Al-awsat Technical University, Health and Medical Technical College, Department of Anesthesia and Critical Care, Kufa, Iraq.
Iran J Med Sci. 2022 May;47(3):194-209. doi: 10.30476/ijms.2021.91753.2291.
Non-invasive ventilation (NIV) is primarily used to treat acute respiratory failure. However, it has broad applications to manage a range of other diseases successfully. The main advantage of NIV lies in its capability to provide the same physiological effects as invasive ventilation while avoiding the placement of an artificial airway and its associated life-threatening complications. The war on the COVID-19 pandemic is far from over. The present narrative review aimed at identifying various aspects of NIV usage, in COVID-19 and other patients, such as the onset time, mode, setting, positioning, sedation, and types of interface. A search for articles published from May 2020 to April 2021 was conducted using MEDLINE, PMC central, Scopus, Web of Science, Cochrane Library, and Embase databases. Of the initially identified 5,450 articles, 73 studies and 24 guidelines on the use of NIV were included. The search was limited to studies involving human cases and English language articles. Despite several reported benefits of NIV, the evidence on the use of NIV in COVID-19 patients does not yet fully support its routine use.
无创通气（NIV）主要用于治疗急性呼吸衰竭。然而，它也广泛应用于成功治疗一系列其他疾病。NIV 的主要优势在于它能够提供与有创通气相同的生理效果，同时避免放置人工气道及其相关的危及生命的并发症。抗击 COVID-19 大流行的战斗远未结束。本叙述性综述旨在确定 NIV 在 COVID-19 患者和其他患者中的各种使用方面，例如发病时间、模式、设置、定位、镇静和接口类型。使用 MEDLINE、PMC 中心、Scopus、Web of Science、Cochrane 图书馆和 Embase 数据库对 2020 年 5 月至 2021 年 4 月发表的文章进行了搜索。在最初确定的 5450 篇文章中，纳入了 73 项关于 NIV 使用的研究和 24 项指南。搜索仅限于涉及人类病例的研究和英文文章。尽管有报道称 NIV 有多种益处，但关于 NIV 在 COVID-19 患者中的使用的证据尚未完全支持其常规使用。
